Changzhou Yabang Pharmaceutical co., ltd.

Complying with GMP, chiefly product for export :
1. pharmaceutical intermediates;
2. Pharmaceutical raw materials;Pharmaceutical raw materials:
Clenbuterol HCL; Propranolol HCL(EP4.0,BP98); Furosemide (BP2002, EP4.0); Telmisartan (Conform); Adrenosem (JPC97); Proglumide (CP2000) Loratadine (Conform); Folic acid (BP2000); Amlodipine Besylate (USP26);
Salbutamol Sulphate (CP2000); Salbutamol (CP2000) ;
Clotrimazole (BP98, USP22); Mexiletine. (BP98);

Activity:

- Manufacturing
- Market Research & Marketing
- Sales & Distribution
- Other Industry Services

Product / Technology type(s) covered:

- API / chemicals
- Generics
- Pharmaceuticals / Therapeutics
- Nutritionals / Vitamins

Therapeutic targets:

- Asthma
- Central nervous system
- Cough / Cold
- Diabetes
- Gastrointestinal
- Hematology
- Infectious Diseases
- Mental Health
- Neurology
- Pain
- Respiratory Medicine

Markets Covered

a. HeadQuarter: China

b. Continent(s) active: Europe , Central/South America , North America , Asia , Australia/New-Zealand , Near/Middle East , Far East , Africa

c. Countries active: Germany; France; Swtizerland; Netherlands; Italy; and so on...

Corporate data:

Number of Employees: 300

Turnover:

Amount:	Year:	Currency:
300million	2002	US Dollar

Year founded: 2000